| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 125, Issue 3 976-980, Copyright © 1980 by American Association of Immunologists
ARTICLES |
ES Gronowicz, CA Doss, FD Howard, DC Morrison and S Strober
An in vitro line of the B cell tumor BCL1 was developed. The cell line carried u-, S-, and A-chains on the cell surface as judged by analysis of surface iodinated proteins but did not secret Ig. ASfter stimulation with LPS, limpid A, or bacterial lipoprotein, 20 to 40% of the tumor cells matured to IgM secretors when detected in a plaque assay. Two other polyclonal B cell activators, namely dextransulphate and PPD, had at most a marginal stimulatory effect. The ability of the cells to become activated to IgM secretion as well as the expression of cell surface IgM and IgD makes the BCL1 unique among murine B cell tumors.
This article has been cited by other articles:
|
|
 |
|
  D. Kim and P. W. Tucker A Regulated Nucleocytoplasmic Shuttle Contributes to Bright's Function as a Transcriptional Activator of Immunoglobulin Genes. Mol. Cell. Biol., March 1, 2006; 26(6): 2187 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. W. Sulentic, M. P. Holsapple, and N. E. Kaminski Putative Link between Transcriptional Regulation of IgM Expression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and the Aryl Hydrocarbon Receptor/Dioxin-Responsive Enhancer Signaling Pathway J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 705 - 716. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. M. Illidge, M. S. Cragg, H. M. McBride, R. R. French, and M. J. Glennie The Importance of Antibody-Specificity in Determining Successful Radioimmunotherapy of B-Cell Lymphoma Blood, July 1, 1999; 94(1): 233 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. L. Tutt, R. R. French, T. M. Illidge, J. Honeychurch, H. M. McBride, C. A. Penfold, D. T. Fearon, R. M. E. Parkhouse, G. G. B. Klaus, and M. J. Glennie Monoclonal Antibody Therapy of B Cell Lymphoma: Signaling Activity on Tumor Cells Appears More Important Than Recruitment of Effectors J. Immunol., September 15, 1998; 161(6): 3176 - 3185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Messika, P. S. Lu, Y.-J. Sung, T. Yao, J.-T. Chi, Y.-h. Chien, and M. M. Davis Differential Effect of B Lymphocyte-induced Maturation Protein (Blimp-1) Expression on Cell Fate during B Cell Development J. Exp. Med., August 3, 1998; 188(3): 515 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-J. Liu, M. Schwen, P. W. Tucker, and B. S. Kim Hybrid Membrane IgM with the Transmembrane Region of I-A{alpha} Facilitates Enhanced Presentation of Distinct Epitopes to T Cells J. Immunol., May 1, 1998; 160(9): 4161 - 4168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. W. Sulentic, M. P. Holsapple, and N. E. Kaminski Aryl Hydrocarbon Receptor-Dependent Suppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin of IgM Secretion in Activated B Cells Mol. Pharmacol., April 1, 1998; 53(4): 623 - 629. [Abstract] [Full Text]
|
|
|
|
|
|
D. Zeng, M. Dick, L. Cheng, M. Amano, S. Dejbakhsh-Jones, P. Huie, R. Sibley, and S. Strober Subsets of Transgenic T Cells That Recognize CD1 Induce or Prevent Murine Lupus: Role of Cytokines J. Exp. Med., February 16, 1998; 187(4): 525 - 536. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
